Biocon to sell 78% in Axicorp

Kiran Majumdar Shaw, CMD of Biocon announces divestment of 78% in the company's German arm - Axicorp GmbH following its global alliance with Pfizer for commercialisation of biosimilar insulin and insulin analogs.

Related Videos